✦ LIBER ✦

Results from CONNECTION: A global, Phase 3 double-blind, placebo-controlled confirmatory trial of dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease

✍ Scribed by Rachelle S. Doody; Pierre Tariot; Jeff Cummings; Bengt Winblad; Bryan Selby; Andria Langenberg; Lynn Seely

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Melissa officinalis extract in the treat

✍ Akhondzadeh, S 📂 Article 📅 2003 🏛 BMJ Publishing Group 🌐 English ⚖ 224 KB

Effect of dimebon on cognition, activiti

✍ Rachelle S Doody; Svetlana I Gavrilova; Mary Sano; Ronald G Thomas; Paul S Aisen 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 211 KB

A 24-week, double-blind, placebo-control

✍ X. A. Alvarez; R. Cacabelos; M. Laredo; V. Couceiro; C. Sampedro; M. Varela; L. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

A long-term, double-blind, placebo-contr

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Efficacy and safety of topical WBI-1001

✍ R. Bissonnette; C. Bolduc; C. Maari; S. Nigen; J.M. Webster; L. Tang; M. Lyle 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

A placebo-controlled, double-blind trial

✍ Gordon K. Wilcock; Sandra Black; Judy Haworth; Mark Laughlin; Suzanne Hendrix; M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB